Company: ChromaDex Corporation
Ticker: Nasdaq: CDXC
Sector: Consumer
Investor Contact: Ben Shamsian

ChromaDex Corporation News

News

ChromaDex Appoints Fadi Karam as Chief Marketing Officer

LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) announced today that it has appointed Fadi Karam as Chief Marketing Officer. Karam has spent his career driving consumer businesses across multiple geographies and cultures, including scaling direct-to-consumer operations...

ChromaDex Corporation Reports 2020 Financial Results

Revenue for the Three-Month Period Ended December 31, 2020 Totals $15.4 Million, up 18% Year-over-Year, with Gross Margin of 61.0%, and Lower Operating Expenses. Full Year Revenue of $59.3 Million, with $47.1 Million from Tru Niagen®. LOS ANGELES - ChromaDex...

ChromaDex to Present at Oppenheimer 31st Annual Healthcare Conference

LOS ANGELES - ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:50pm ET (12:50pm PT). A webcast of the presentation will be posted under the...

Skip to content